A phase II trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: a trial of the Eastern Cooperative Oncology Group (E1303)

A phase II trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck: a trial of the Eastern Cooperative Oncology Group (E1303)

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer 2011-01, Vol.117 (15), p.3374-3382
Hauptverfasser: Argiris, Athanassios, Ghebremichael, Musie, Burtness, Barbara, Axelrod, Rita S., Deconti, Ronald C., Forastiere, Arlene A.
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:
ISSN:0008-543X
1097-0142
DOI:10.1002/cncr.25852